Aterian Revenue Drops 30% in Fiscal Q2

Aterian (NASDAQ:ATER) reported a challenging Q2 2025, with GAAP revenue declining 30.4% year-over-year to $19.5 million, missing analyst estimates, and GAAP loss per share widening to $(0.63). The consumer products company experienced significant margin compression, with gross margin falling to 54.3% and Adjusted EBITDA turning to a $(2.2) million loss, primarily due to lower unit sales from consumer pushback on tariff-driven price hikes and soft demand. While Aterian is implementing cost-cutting measures and seeking to diversify its supply chain and sales channels beyond Amazon, these strategic shifts are in early stages, leading to a cautious H2 2025 outlook that projects only modest revenue stability and narrowing losses amid continued market uncertainty.

Analysis

Aterian's Q2 2025 results highlight a company under significant financial and operational pressure. GAAP revenue declined sharply by 30.4% year-over-year to $19.5 million, missing analyst estimates, while the GAAP loss per share widened to $(0.63), also below expectations. The primary drivers for this underperformance were lower unit sales stemming from consumer pushback against tariff-related price increases and a continued heavy reliance on the Amazon marketplace, which constituted 92% of 2024 sales. Profitability metrics deteriorated significantly; GAAP gross margin contracted 6.1 percentage points to 54.3%, and the non-GAAP contribution margin collapsed to 7.8% from 17.4% a year prior, indicating that cost pressures are severely outpacing pricing power. This led to an Adjusted EBITDA loss of $(2.2) million, a stark reversal from a $0.2 million profit in Q2 2024. While the company is executing a turnaround plan involving cost-cutting and supply chain diversification away from China, these initiatives are in their early stages. Restructuring charges of $1.8 million offset some cost savings, and the balance sheet shows signs of strain with rising inventory ($18.5 million) and limited cash ($10.5 million). Management's H2 2025 guidance for $36-$38 million in revenue and an Adjusted EBITDA between $0 and $(1.0) million projects stabilization but remains contingent on the successful rollout of new consumable products and navigating a volatile consumer environment.

Key Decisions for Investors

• Given the substantial revenue decline, severe margin compression, and ongoing cash burn, Aterian should be treated as a high-risk turnaround story, with close scrutiny of its liquidity in the upcoming quarters.
• The success of the turnaround is contingent on the execution of its strategic pivots, so investors should monitor for tangible evidence of sales channel diversification away from Amazon and material revenue contribution from the new consumables line in H2 2025.
• While management's guidance suggests narrowing losses, it is predicated on operational improvements and a new product rollout in a weak consumer spending environment; downside risk remains significant if these milestones are not met or are delayed.
• Investors should weigh the potential for future cost savings and strategic shifts against the current reality of negative EBITDA, missed financial targets, and heavy dependence on a single sales channel before initiating or adding to a position.